The Kislinger Laboratory is located at the Princess Margaret Cancer Research Tower of the Princess Margaret Cancer Centre, the largest oncology treatment and research facility in Canada. The major goal of our lab is to apply proteomics technologies to cancer and cardiovascular research. Our research interests include technology development, using the latest generation of mass spectrometry instrumentation, basic cell biology and translational cancer research.
N-Glycoproteomics of Patient-Derived Xenografts: A Strategy to Discover Tumor-Associated Proteins in High-Grade Serous Ovarian Cancer.
Cell Syst. 2019 Apr 24;8(4):345-351.e4
Cancer Cell. 2019 Mar 18;35(3):414-427.e6
Minimal information for studies of extracellular vesicles 2018 (MISEV2018): a position statement of the International Society for Extracellular Vesicles and update of the MISEV2014 guidelines.
J Extracell Vesicles. 2018;7(1):1535750
PLoS Biol. 2018 Jun 20;16(6):e2004049
J Cell Biol. 2018 Jun 19;:
Proteomic Analysis of Cancer Associated Fibroblasts Reveal a Paracrine Role for MFAP5 in Human Oral Tongue Squamous Cell Carcinoma.
J Proteome Res. 2018 Apr 22;:
Expert Rev Proteomics. 2018 Jan 18;:
Proteomic Profiling of Secreted Proteins, Exosomes, and Microvesicles in Cell Culture Conditioned Media.
Methods Mol Biol. 2018;1722:91-102
Divergent evolution of temozolomide resistance in glioblastoma stem cells is reflected in extracellular vesicles and coupled with radiosensitization.
Neuro Oncol. 2017 Jul 28;:
Proteomics. 2017 Sep 18;:
Senior Scientist, Princess Margaret Cancer Centre